Influence of Different Hydroxyethyl Starch (HES) Formulations on Fibrinogen Measurement in HES-Diluted Plasma

被引:29
作者
Adam, Susanne [1 ]
Karger, Ralf [1 ]
Kretschmer, Volker [1 ]
机构
[1] Univ Hosp Marburg, Inst Transfus Med & Hemostaseol, Marburg, Germany
关键词
fibrinogen concentration; fibrinogen measurement; hydroxyethyl starch; major blood loss; massive transfusion; volume replacement; IN-VITRO; CLOT FORMATION; COAGULOPATHY; COAGULATION; ASSAYS; SUBSTITUTES; CONCENTRATE; TRANSFUSION; HEMOSTASIS; GUIDELINES;
D O I
10.1177/1076029609336855
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Fibrinogen is the first coagulation factor becoming critical in dilution coagulopathy. Volume replacement in major blood loss is performed with large volumes of crystalloid and colloid solutions. The latter has been shown to compromise accurate photo-optical measurement of fibrinogen. This study determined the influence of different hydroxyethyl starch (HES) formulations. Methods: Citrated plasma samples of 8 healthy volunteers were diluted by 30% or 50% with either HES 10% (200/0.5; HES-200), HES 6% (70/0.5; HES-70), or HES 6% (450/0.7; HES-450). Fibrinogen concentrations were determined by photo-optical measurement (Behring coagulation system [BCS]: derived fibrinogen, or Clauss fibrinogen, calibrated for high [CLS] or low fibrinogen concentrations [CLS-low]) as well as mechanical end point determinations (KC4: CLS-KC4). Measured values were compared with calculated values. Results: On average and across all photo-optical methods, fibrinogen concentrations were overestimated, particularly with HES-200. Hydroxyethyl starch-70 and HES-450 did not differ much from each other. Overestimation was relatively greater for 50% dilutions with all HES formulations. Surprisingly, overestimation was most prominent with CLS-low, the method supposed to most reliably measure low fibrinogen concentrations; overestimation amounted to 92% and 120% with HES-200, 54% and 73% with HES-70, and 51% and 79% with HES-450, for 30% and 50% dilutions, respectively. In contrast, CLS-KC4 always yielded sufficiently accurate results. Conclusions: The study showed that all HES solutions more or less impaired the fibrinogen measurement with the photo-optical method. In particular, overestimation with CLS-low may prevent timely fibrinogen replacement in major blood loss. Hydroxyethyl starch concentration appears to be more relevant for this effect than its molecular size.
引用
收藏
页码:454 / 460
页数:7
相关论文
共 18 条
[1]   Effects of different plasma substitutes on blood coagulation: A comparative review [J].
de Jonge, E ;
Levi, M .
CRITICAL CARE MEDICINE, 2001, 29 (06) :1261-1267
[2]   Fibrinogen concentrate reverses dilutional coagulopathy induced in vitro by saline but not by hydroxyethyl starch 6% [J].
De Lorenzo, C ;
Calatzis, A ;
Welsch, U ;
Heindl, B .
ANESTHESIA AND ANALGESIA, 2006, 102 (04) :1194-1200
[3]   Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes:: improvements of the induced coagulopathy with fibrinogen concentrate [J].
Fenger-Eriksen, C ;
Anker-Moller, E ;
Heslop, J ;
Ingerslev, J ;
Sorensen, B .
BRITISH JOURNAL OF ANAESTHESIA, 2005, 94 (03) :324-329
[4]   The effect of the combined administration of colloids and lactated Ringer's solution on the coagulation system:: An in vitro study using Thrombelastograph® coagulation analysis (ROTEG®) [J].
Fries, D ;
Innerhofer, P ;
Klingler, A ;
Berresheim, U ;
Mittermayr, M ;
Calatzis, A ;
Schobersberger, W .
ANESTHESIA AND ANALGESIA, 2002, 94 (05) :1280-1287
[5]   RETRACTED: Influence of a new hydroxyethylstarch preparation (HES 130/0.4) on coagulation in cardiac surgical patients (Retracted article. See vol. 25, pg. 755, 2011) [J].
Haisch, G ;
Boldt, J ;
Krebs, C ;
Suttner, S ;
Lehmann, A ;
Isgro, F .
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2001, 15 (03) :316-321
[6]   RETRACTED: The influence of intravascular volume therapy with a new hydroxyethyl starch preparation (6% HES 130/0.4) on coagulation in patients undergoing major abdominal surgery (Retracted Article) [J].
Haisch, G ;
Boldt, J ;
Krebs, C ;
Kumle, B ;
Suttner, S ;
Schulz, A .
ANESTHESIA AND ANALGESIA, 2001, 92 (03) :565-571
[7]   Massive transfusion and coagulopathy: pathophysiology and implications for clinical management [J].
Hardy, Jean-Francois ;
de Moerloose, Philippe ;
Samama, Charles Marc .
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 2006, 53 (06) :S40-S58
[8]   High dose fibrinogen administration for acute therapy of coagulopathy during massive perioperative transfusion [J].
Heindl, B ;
DeLorenzo, C ;
Spannagl, M .
ANAESTHESIST, 2005, 54 (08) :787-790
[9]  
Hiippala ST, 1995, BLOOD COAGUL FIBRIN, V6, P743
[10]   The effects of perioperatively administered colloids and crystalloids on primary platelet-mediated hemostasis and clot formation [J].
Innerhofer, P ;
Fries, D ;
Margreiter, J ;
Klingler, A ;
Kühbacher, G ;
Wachter, B ;
Oswald, E ;
Salner, E ;
Frischhut, B ;
Schobersberger, W .
ANESTHESIA AND ANALGESIA, 2002, 95 (04) :858-865